|
Guidelines for surgical treatment of laryngeal cancer |
R1 |
A |
Diagnosis and work up of laryngeal cancer |
|
A1 |
What is the role of a laryngoscopic examination and voice analysis in the diagnosis of laryngeal cancer? |
R2 |
A2 |
What are the roles of computed tomography and magnetic resonance for the diagnosis of laryngeal cancer? |
R3 |
A3 |
What is the role of positron emission tomography/computed tomography in a preoperative evaluation of laryngeal cancer? |
R4 |
A4 |
What is the role of ultrasonography in the staging of laryngeal cancer? |
R5 |
A5 |
How we can evaluate patients' preoperative general conditions? |
|
A5-1 |
Assessment of patients who are eligible for laryngectomy |
R6 |
A5-2 |
Screening assessment of second primary cancers (synchronous and metachronous head and neck carcinomas) |
R7 |
A5-3 |
Risk factors for laryngeal cancer |
R8 |
B |
Premalignant lesion of larynx |
|
B1 |
What is the appropriate management for a premalignant laryngeal lesion? |
|
B1-1 |
Definition of premalignant laryngeal lesion |
|
B1-2 |
Diagnostic procedure for a premalignant laryngeal lesion |
R9 |
B1-3 |
Approach for a premalignant laryngeal lesion |
R10 |
B1-4 |
Follow-up of premalignant lesions |
R11 |
C |
Glottis cancer |
|
C1 |
What is the appropriate surgery for a primary T1/T2 glottic cancer? |
R12 |
C2 |
What is the proper surgical management for T3/T4 glottic cancer? |
R13 |
C3 |
What is the appropriate management of the neck lymph nodes in glottic cancer? |
|
C3-1 |
Management for clinically positive neck (N+) in patients with glottic cancer |
R14 |
C3-2 |
Management for clinically negative neck (N0) in patients with glottic cancer |
R15 |
D |
Supraglottic cancer |
|
D1 |
What is the appropriate surgical treatment for a supraglottic primary site? |
|
D1-1 |
Surgical treatment for T1/T2 supraglottic cancer |
R16 |
D1-2 |
Surgical treatment for T3/T4 supraglottic cancer |
R17 |
D2 |
What comprises appropriate neck lymph node management in supraglottic cancer? |
|
D2-1 |
Management for clinically positive neck (N+) in patients with supraglottic cancer |
R18 |
D2-2 |
Management for clinically negative neck (N-) in patients with supraglottic cancer |
R19 |
E |
Postoperative risk stratification/rehabilitation/long-term follow-up |
|
E1 |
How we can stratify the risk of recurrence in postoperative laryngeal cancer patients? To which patients should postoperative adjuvant therapy be administered? |
|
E1-1 |
Postoperative management and complications |
R20 |
E1-2 |
Adjuvant treatment |
R21 |
E2 |
Postoperatively, what types of rehabilitation and/or psychiatric support are required for patients with laryngeal cancer? |
|
E2-1 |
Swallowing rehabilitation |
R22 |
E2-2 |
Voice rehabilitation methods after total laryngectomy |
R23 |
E2-3 |
Shoulder dysfunction after neck dissection |
R24 |
E2-4 |
Counselling for smoking cessation |
R25 |
E2-5 |
Psychiatric consultation |
R26 |
E3 |
How can we postoperatively follow-up patients with laryngeal cancer? |
|
E3-1 |
Long-term follow-up schedule |
R27 |
E3-2 |
Tests during the follow-up period |
R28 |
E3-3 |
Thyroid function evaluation |
R29 |
F |
Salvage surgery |
|
F1 |
What is the appropriate surgery for recurrent laryngeal cancer? |
|
F1-1 |
Salvage surgery for a local failure of non-surgical treatment |
R30 |
F1-2 |
Management of the NO neck during salvage surgery after non-surgical treatment |
R31 |
F1-3 |
Salvage surgery for recurrence after surgical therapy |
R32 |